Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Safety and Efficacy of Abatacept in IgG4-Related Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
- Status
- COMPLETED
- Phase
- PHASE2
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread
- Status
- COMPLETED
- Phase
- N/A
Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia
- Status
- COMPLETED
- Phase
- N/A
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- N/A
A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
- Status
- TERMINATED
- Phase
- PHASE1
Rheumatoid Arthritis Memory B Cells and Abatacept
- Status
- COMPLETED
- Phase
- PHASE4
Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells
- Status
- COMPLETED
- Phase
- N/A
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of a Personalized Neoantigen Cancer Vaccine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2